Non-alcoholic Steatohepatitis
Gilead and Novo Nordisk Present Proof-of-Concept Data for the First Possible NASH Treatment
2020-11-17
LATEST
Study Finds Treatment Variations in Immunobullous Disorders Linked to Demographic Factors
2026-01-24
Study Finds Orexin Receptor Agonists May Pose Higher Fracture Risk Compared to Melatonin Receptor Agonists
2026-01-24
Researchers Develop Distributed Method Using Control Barrier Functions to Enhance Network Connectivity
2026-01-24



